儿童间质性肺病分类、评估与管理更新:ATS临床实践指南
美国胸科学会基于GRADE方法更新了2岁以下儿童间质性肺病(chILD)的临床实践指南,针对基因检测、胸部影像、肺活检和肺移植转诊提出推荐。指南建议对合并呼吸衰竭的chILD婴儿进行快速广泛基因检测(强推荐),胸部CT仍为诊断评估的重要部分(条件推荐),并明确了肺活检和肺移植转诊的适用情形。
要点
- 合并呼吸衰竭的chILD婴儿应行快速广泛基因检测(强推荐)。
- 胸部CT仍是chILD诊断评估的重要部分(条件推荐)。
- 需紧急明确病因且基因检测不可行/不及时/不明确、或需识别可治疗组织病理特征或判断预后时,推荐外科肺活检(强推荐)。
核心结论
- 指南为2岁以下chILD患儿的基因检测、胸部影像、肺活检和肺移植转诊提供了循证推荐,以改善诊断评估与管理。
研究设计与样本
- 美国胸科学会(ATS)制定,采用GRADE方法形成临床问题、汇总证据并制定推荐,由多学科专家组针对诊断工具和肺移植评估转诊提出推荐。
主要发现
- 对合并呼吸衰竭的chILD婴儿推荐快速广泛基因检测(强推荐)。
- 胸部CT仍是诊断评估的重要部分(条件推荐)。
- 在需紧急明确特定chILD疾病且基因检测不可行、不及时或不 conclusive 时,或需识别组织病理「可治疗特征」或判断预后时,推荐外科肺活检(强推荐)。
- 对具有可预测不良结局的特定chILD疾病患儿,推荐转诊进行肺移植评估(强推荐)。
- 对2岁前诊断的chILD患儿,建议重复胸部CT以辅助决策、判断预后和/或调整治疗(条件推荐)。
关键数值与推荐
- 合并呼吸衰竭的chILD婴儿:快速广泛基因检测(强推荐)。
- 胸部CT:诊断评估的重要部分(条件推荐)。
- 外科肺活检:需紧急明确特定chILD疾病且基因检测不可行、不及时或不 conclusive,或需识别组织病理「可治疗特征」或判断预后时(强推荐)。
- 肺移植评估转诊:具有可预测不良结局的特定chILD疾病患儿(强推荐)。
- 重复胸部CT:2岁前诊断的chILD患儿,用于辅助决策、判断预后和/或调整治疗(条件推荐)。
临床怎么用
- 对2岁以下chILD患儿,尤其合并呼吸衰竭者,应优先安排快速广泛基因检测。
- 胸部CT应作为chILD诊断评估的组成部分,并在2岁前诊断的患儿中可考虑重复CT辅助决策。
- 符合指征时(基因检测不可行/不及时/不明确、需识别可治疗组织病理特征或判断预后)应行外科肺活检,特定不良预后疾病患儿应转诊肺移植评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Am J Respir Crit Care Med. 2026 Oct 1;212(10):2308-2337. doi: 10.1093/ajrccm/aamag375. ABSTRACT BACKGROUND: Childhood interstitial lung diseases (chILD) are a heterogeneous group of rare disorders. In 2013, the American Thoracic Society (ATS) developed a guideline regarding the classification, evaluation, and management of children <2 years old with chILD. The current guideline provides updated recommendations regarding genetic testing, chest imaging, lung biopsy, and lung transplant referral. METHODS: The Grading of Recommendations, Assessment, Development, and Evaluation approach was used to form clinical questions, summarize evidence, and develop recommendations, following ATS policies and procedures. A multidisciplinary panel with expertise in chILD formulated recommendations addressing diagnostic tools and referral for lung transplant evaluation. RESULTS: Rapid and broad genetic testing is recommended for infants with chILD and respiratory failure (strong recommendation). Chest computed tomography (CT) remains an important part of the diagnostic evaluation (conditional recommendation). Surgical lung biopsy is recommended when there is urgency to identify a specific chILD disorder and genetic testing is not feasible, timely, or inconclusive; to identify histopathologic "treatable traits"; or to inform prognosis (strong recommendation). Referral for lung transplant evaluation is recommended for children with specific chILD disorders with predictable poor outcomes (strong recommendation). Repeat chest CT to aid decision-making, prognosis, and/or change therapies is suggested for children with chILD diagnosed before age 2 years (conditional recommendation). CONCLUSIONS: This guideline provides evidence-based recommendations for genetic testing, chest imaging, lung biopsy, and referral for lung transplant evaluation to improve the diagnostic evaluation and management of children <2 years with chILD. Implementing this guideline will hopefully increase genetic testing for chILD, inform the diagnostic evaluation and disease monitoring of chILD, and identify future research priorities for chILD. PMID: 42496593 | DOI: 10.1093/ajrccm/aamag375
引用
- 指南共识 · 间质性肺病:An update to the classification, evaluation, and management of childhood interstitial lung disease in infancy: an official American Thoracic Society Clinical Practice Guideline
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。